1380P Phase (Ph) II study of zanidatamab + chemotherapy (chemo) in first-line (1L) HER2 expressing gastroesophageal adenocarcinoma (GEA)
Geoffrey Y. Ku, Elena Elimova, C.S. Denlinger, Ram Sharan Mehta, Kyung-Woo Lee, Syma Iqbal, Y-K. Kang, D. Oh, Sun Young Rha, Yeul Hong Kim, Young Mi Seol, T. Mwatha, J. Grim, Jaffer A. Ajani
Topics & Concepts
MedicineInternal medicineHypokalemiaOxaliplatinGastroenterologyVomitingNauseaCapecitabineAdverse effectCancerColorectal cancerHER2/EGFR in Cancer ResearchGastric Cancer Management and OutcomesPeptidase Inhibition and Analysis